A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients
Clinical trial NCT07281001 · RECRUITING
Trial details
- NCT number
- NCT07281001
- Sponsor
- Blokhin's Russian Cancer Research Center
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.